Phil Cyr, Senior Vice President, Precision Value & Health, discussed challenges to tackle with CAR T-cell therapies.
Phil Cyr
Advertisement
Articles by Phil Cyr
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
2
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
3
FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program
4
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
5
